Casgevy (exagamglogene autotemcel)
pCPA File Number:
22972
Negotiation Status:
Active Negotiation
Indication(s):
Sickle cell disease
Sponsor/Manufacturer:
Vertex Pharmaceuticals (Canada) Incorporated
CDA-AMC Project Number:
SG0830-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable